Assignment of Assignor's Interest

Recorded: 2023-05-03 Pages: 7

Assignor

TABUTEAU, HERRIOT

Executed: 2023-04-28

Assignee

ANTECIP BIOVENTURES II LLC

630 FIFTH AVENUE, SUITE 2000, NEW YORK, NEW YORK, 10111

Covered Properties (13)

Bupropion Dosage Forms with Reduced Food and Alcohol Dosing Effects

Patent: 11,717,518 →

Application: 18/157,393 →

Treatment of Depression in Certain Patient Populations

Patent: 11,730,706 →

Application: 18/158,268 →

Treatment of Poor Metabolizers of Dextromethorphan with a Combination of Bupropion and Dextromethorphan

Patent: 12,036,191 →

Application: 18/169,571 →

Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions

Patent: 11,752,144 →

Application: 18/173,291 →

Method of Maintaining Remission of Depressive Symptoms

Application: 18/174,278 →

Publication: US US20230210843A1

Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions

Patent: 11,839,612 →

Application: 18/177,585 →

Bupropion as a Modulator of Drug Activity

Application: 18/179,196 →

Publication: US US20230218550A1